Curcuma longa L. Extract and Photodynamic Therapy are Effective against Candida spp. and Do Not Show Toxicity In Vivo

Marques Meccatti, Vanessa; de Souza Moura, Larissa; Guerra Pinto, Juliana; Ferreira-Strixino, Juliana; Abu Hasna, Amjad; Alves Figueiredo-Godoi, Lívia Mara; Campos Junqueira, Juliana; Marcucci, Maria Cristina; Paula Ramos, Lucas de; Carvalho, Claudio Antonio Talge; Pucci, Cesar Rogério; de Oliveira, Luciane Dias

doi:https://doi.org/10.1155/2022/5837864

International Journal of Dentistry

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 5837864 | https://doi.org/10.1155/2022/5837864

Curcuma longa L. Extract and Photodynamic Therapy are Effective against Candida spp. and Do Not Show Toxicity In Vivo

Vanessa Marques Meccatti,¹Larissa de Souza Moura,¹Juliana Guerra Pinto,²Juliana Ferreira-Strixino,²Amjad Abu Hasna,³Lívia Mara Alves Figueiredo-Godoi,¹Juliana Campos Junqueira,¹Maria Cristina Marcucci,¹Lucas de Paula Ramos,¹Claudio Antonio Talge Carvalho,³Cesar Rogério Pucci,⁴and Luciane Dias de Oliveira¹

Academic Editor: Halim Issever

Received29 Dec 2021

Revised30 May 2022

Accepted15 Jun 2022

Published01 Jul 2022

Abstract

Radiotherapy induces a higher level of Candida spp. colonization, resulting in oral candidiasis. This study aimed to evaluate the phototransformation potential of the glycolic extract of Curcuma longa (C. longa); the antifungal activity of C. longa, curcumin, and antifungal photodynamic therapy (aPDT) with blue light-emitting diodes “LED” on Candida albicans and Candida tropicalis in vitro; and the toxicity of C. longa and curcumin in Galleria mellonella model. In order to confirm the light absorption capacity of the C. longa extract, its phototransformation potential was evaluated. The antifungal effect of C. longa, curcumin, and aPDT was evaluated over Candida spp. Finally, the toxicity of C. longa and curcumin was evaluated on the Galleria mellonella model. The data were analyzed using the GraphPad Prism 5.0 software considering α = 5%. It was found that C. longa, curcumin, and aPDT using blue LED have an antifungal effect over C. albicans and C. tropicalis. The extract of C. longa 100 mg/mL and curcumin 200 μg/mL do not show toxicity on Galleria mellonella model.

1. Introduction

Radiotherapy is a nonsurgical technique, and it is used to treat a variety of tumors by destroying cancer cells using X-rays, gamma rays, and other high-energy particles [1]. However, it causes oral candidiasis and radiation-induced oral mucositis [2] as it induces a higher level of Candida spp. colonization [3]. These yeasts have the ability to form biofilms and germ tubes, and they possess adhesion proteins and enzymes at the ends of hyphae that contribute to their diffusion into host tissues [4].

Candida albicans (C. albicans) is the main species responsible for causing oral candidiasis [5]. It has the ability to grow in anaerobiosis and has a role in endodontic and periodontal infections [6, 7]. Besides, Candida tropicalis (C. tropicalis), the yeast that has a high capacity for adhesion and biofilm formation, has a role in fungal infections [8].

Currently, there are four main types of antifungal drugs including polyenes, azoles, allylamines, and echinocandins [9]. However, the incidence of fungal resistance to these drugs has increased [10] because of the excessive and uncontrolled use of antifungal drugs [11], in addition to the morphological and physiological changes provoked by radiotherapy; thus, the patients are becoming more susceptible to colonization by these yeasts [12], and only limited treatment options are effective for oral candidiasis [13].

Antimicrobial or antifungal photodynamic therapy (aPDT) consists of the combination of a photosensitizer with a light source that will produce reactive oxygen species [14] causing a cytotoxic effect on cancerous or microbial cells [15]. Some herbal medicines were tested and found effective over resistant microorganisms [16, 17] beside being biocompatible [18]. Turmeric, Curcuma longa (C. longa), is a flowering plant of the ginger family, Zingiberaceae [19]. C. longa has curcumin, the herbal medicine, in which both have been widely studied for application in aPDT because of its molecular nature [20], effect over tumor cells [21, 22], and antifungal effect [23].

Diverse studies in the literature evaluated the effect of curcumin through aPDT over C. albicans [24, 25]. However, to the best of our knowledge, there is only one study that evaluated its effect over C. tropicalis [26], and there are no studies that evaluated the effect of glycolic extract of C. longa as a photosensitizer for aPDT over Candida spp. In addition, to advance toward the therapeutic use of the natural product, it is essential to study the toxicity of photosensitizers in vivo. Therefore, the aim of this study was to evaluate (I) the phototransformation potential of the glycolic extract of C. longa; (II) the antifungal activity of C. longa, curcumin, and aPDT with blue light-emitting diodes “LED” on C. albicans and C. tropicalis in vitro; (III) the toxicity of C. longa and curcumin in Galleria mellonella (G. mellonella) model. The null hypothesis was that C. longa, curcumin, and aPDT have no antifungal effect and are toxic.

2. Material and Methods

2.1. Fungus Strains and Plant Extract

The reference strains (ATCC, American Type Culture Collection) of C. albicans (ATCC 18804) and C. tropicalis (ATCC 13803), were used in the study and were obtained from the Laboratory of Microbiology and Immunology of the Institute of Science and Technology of São Paulo State University (ICT-UNESP).

The glycolic extract of C. longa (Seiva Brazilis, São Paulo, SP, Brazil) was obtained commercially at a concentration of 20% (200 mg/mL). The curcumin was produced by PDT Pharma (PDT Pharma, Cravinhos, SP, Brazil) and was provided by the Biophotonics Laboratory, Institute of Physics, University of São Paulo, São Carlos. According to the supplier’s instructions, curcumin was initially diluted in a dimethylsulfoxide (DMSO) solution (at 1% of the final volume) and ethanol p.a. and then was kept as a stock solution. Posteriorly, it was diluted in phosphate buffer solution (PBS) to be tested.

2.2. Absorption Spectrum

To confirm the light absorption capacity of the C. longa extract and evaluate the possibility to be used as a photosensitizer, its phototransformation potential was evaluated. Aliquots of the plant extract at different dilutions were placed in cuvettes and subjected to analysis of optical characteristics. These were obtained through absorbance spectrum in a spectrophotometer (DeNovix DS-11, Wilmington, DE, United States) at the Nanosensors Laboratory of the Research and Development Institute of the University of Vale do Paraiba. This equipment is capable of performing the full-spectrum analysis in microvolumes, using the UV-Vis technique (190–840 nm).

2.3. Experimental Groups and Antifungal Photodynamic Therapy “aPDT” over Candida spp

(i)Group 1: Sterile saline solution (NaCl 0.9%) (negative control group).(ii)Group 2: Nystatin (100.000 UI/mL) (positive control group).(iii)Group 3: C. longa extract (100 mg/mL).(iv)Group 4: Curcumin (200 μg/mL).(v)Group 5: LED. The irradiation was performed using a prototype A LED-based device (Biotable Irrad/LED), with a wavelength of 450 ± 5 nm and a power of 3 W per LED.(vi)Group 6: aPDT: curcumin + blue LED.

Standardized inoculum of each strain was prepared of culture seeded on Sabouraud-Dextrose agar (SD, HiMedia, Mumbai, India) and in yeast extract-peptone-dextrose (YPD) broth after 24 h of incubation at 37°C. The inoculum was centrifuged at 5,000 rpm for 10 min (MPW 350-Med. Instruments, Poland), and the supernatant was discarded. The remaining deposit was resuspended in sterile saline solution (NaCl 0.9%) and homogenized in a Vortex for 10 s. This procedure was repeated twice to obtain a standardized inoculum of C. albicans and C. tropicalis by using a spectrophotometer (Micronal B-582, São Paulo, Brazil) at 530 nm and an optical density of 1.258 in a concentration of 1 × 10⁸ yeast cells per milliliter.

Aliquots of these standardized inoculums were distributed in 15 mL tubes according to the experimental groups and were centrifuged (5000 rpm for 10 min). The supernatant was discarded. The tubes corresponding to groups 1 and 5 received a saline solution, the group 2 was treated with nystatin, the group 3 were resuspended in the extract of C. longa L (100 mg/mL), and the groups 4 and 6 were resuspended in the extract of curcumin at the predetermined concentrations (200 μg/mL). Then, they were homogenized in Vortex for 10 s and incubated at 37°C for 20 min, in the absence of light, considering this period as the preirradiation time (PIT). Then, the tubes were centrifuged again, the supernatant was discarded, and the remaining deposit of fungal cells from all groups was resuspended in saline solution. Aliquots of these final suspensions from the tubes were distributed in 24-well plates, where n = 10. The plates containing the groups 5 and 6 received irradiation of 10 J/cm²; 110 mW/cm² for 91 s (1^st irradiance protocol) or 25 J/cm², 110 mW/cm² for 228 s (2^nd irradiance protocol). Groups 1, 2, 3, and 4 were kept in the dark for the same period of irradiation. Finally, serial dilutions were performed and 20 μL of each dilution were seeded on Sabouraud-Dextrose agar using the drop technique. After 48 h of incubation, the colony-forming units per milliliter (CFU/mL) were counted.

2.4. Evaluation of Toxicity on Invertebrate Model G. mellonella

The concentrations used in the in vitro tests (100 mg/mL of the C. longa extract and 200 μg/mL of curcumin) were inoculated in the last right proleg of larvae in order to verify toxicity. A group consisting of 15 larvae was selected for each product and, as a control, a group of larvae were inoculated with PBS in the proleg on the right side. A 10 μL aliquot of each substance was inoculated with Hamilton syringes (Hamilton Inc., USA), and then the larvae were kept in Petri dishes at 37°C in the dark, without nutrition. After 24 hours of inoculations, the number of dead G. mellonella was recorded daily up to 168 hours (7 days) for analysis of the survival curve. Larvae were considered dead when they showed no movement after touching.

2.5. Statistical Analysis

The data normality was analyzed by using the following tests: Shapiro–Wilk, Kolmogorov–Smirnov, and D’Agostino and Pearson omnibus and for homogeneity using the BioEstat 5.0 software. Then, ANOVA and Tukey’s test were used for parametric data, and the Kruskal–Wallis test and Dunn’s test for nonparametric data. The data obtained in the survival curve of G. mellonella were analyzed by the log-rank method using the GraphPad Prism 5.0 software. In all tests, a significance level of 5% was considered.

3. Results

3.1. Absorption Spectrum

The C. longa extract was not able to absorb light in the 450 nm wavelength range (Figure 1). The phototransformation potential test was carried out with different concentrations of the plant extract (200, 100, and 50 mg/mL) diluted in saline solution S. Therefore, it was tested as an herbal extract rather than a photosensitizer in the CFU/mL.

3.2. Antifungal Photodynamic Therapy “aPDT” over Candida spp

For the 1^st irradiation protocol (10 J/cm² and 110 mW/cm²) against C. albicans, there was no statistically significant difference among all experimental groups (Figure 2(a)). For the 2^nd irradiation protocol (25 J/cm²·and 110 mW/cm²) against C. albicans, the C. longa extract was able to promote almost 1 log reduction and had no statistically significant difference with the aPDT group (LED + curcumin). However, the aPDT group was more effective than the C. albicans group and it had a statistically significant difference from all other groups (Figure 2(b)).

(a)

(b)

For the 1^st irradiation protocol (10 J/cm² and 110 mW/cm²) and the 2^nd irradiation protocol (25 J/cm²·e 110 mW/cm²) against C. tropicalis, the groups of nystatin and aPDT were effective over the yeast and had a statistically significant difference of all groups except the C. longa group. In the 1^st irradiation protocol, it was observed that the aPDT group was able to promote almost 4 log reduction and in the 2^nd irradiation protocol, it was able to promote almost 5 log reduction. The C. longa extract applied alone was able to promote almost 1 log reduction and when compared to the aPDT or nystatin group, it did not show any difference (Figures 3(a) and 3(b)).

(a)

(b)

3.3. Evaluation of Toxicity of C. longa and Curcumin on Invertebrate Model G. mellonella

The toxicity analysis of the C. longa extract (100 mg/mL) and curcumin (200 μg/mL) was also performed by testing the survival curve of larvae evaluated for 7 days after inoculation. Figure 4 shows the statistical similarity between the groups of herbal and control products (PBS) with (). The products derived from C. longa do not show toxicity in the invertebrate model.

4. Discussion

PDT is a promising alternative therapy that has emerged in dentistry for the treatment of oral cavity infections [15, 27, 28]. This study was elaborated to evaluate the antifungal effect of C. longa, curcumin (as photosensitizer or herbal extract), and aPDT over C. albicans and C. tropicalis. The null hypothesis was rejected.

An important parameter to assess the photodynamic effectiveness of a photosensitizer is the analysis of the number of absorbed photons needed to cause the transformation of a fixed amount of sensitizer. To confirm the light absorption capacity of C. longa extract, its phototransformation potential was evaluated. It was found that the C. longa extract was not able to absorb light in the 450 nm wavelength range (Figure 1). However, different results were reported in the literature found that the C. longa extract has a spectrum similar to the phytochemical curcumin isolated in the range from 400 to 440 nm [29].

In this study, it was opted to apply curcumin but not C. longa as a photosensitizer, based on the literature, the molecular nature and potential of absorption of curcumin light are well described [30, 31]. According to the literature, curcumin absorbs light within the entire visible spectrum of blue, in the range from 300 to 500 nm [32] and its maximum absorbance was verified at an average of 418 nm depending on the solvents used [33].

However, over C. albicans, curcumin promoted a reduction in the CFU/mL count when using the second irradiation protocol (110 mW/cm²; 25 J/cm² for 228 s) with a PIT of 20 min. Similar results were reported previously, in which a decrease in the viability of planktonic cells and C. albicans biofilm (22 mW/cm², 5.28 J/cm², 455 nm, 240 s) using curcumin as a photosensitizer with PIT of 20 min. Curcumin, as a lipophilic molecule, interacts directly with the membrane and membrane proteins, which explains why prolonged preirradiation times are not necessary [34]. The study of Ma et al. evaluated the use of PDT against ATCC and clinical strains of C. albicans, comparing different irradiation protocols, and found a time-dependent decrease in cell viability, as the longer the irradiation time, the higher the light dose used and consequently, greater inhibition of C. albicans [35]. In the present study, it was also observed a greater reduction in CFU/mL when the protocol with a long time and light dose was used, especially in C. tropicalis.

In the present study, the C. longa extract was effective alone over C. albicans. In the literature, fifteen plant extracts were evaluated for antifungal activity on clinical strains of C. albicans and the extract of C. longa was among the five herbal medicines that showed the best inhibitory effect and potential for controlling the growth of this yeast [36]. The turmeric extract was also evaluated for its potential to mediate PDT on planktonic cultures and Enterococcus faecalis biofilm and for toxicity on fibroblast cultures. The action of the herbal medicine as a photosensitizer was able to promote significant microbial reduction and produce cell viability similar to the methylene blue dye [29].

To advance toward the therapeutic use of the natural product, it is essential to study the toxicity of photosensitizers in vivo. G. mellonella is a widely used animal model that has interesting applicability. Investigations of the toxicity of substances in this in vivo model are of great importance, as they will enable the reduction of vertebrate animals for the same purpose.

The C. longa extract has antifungal activity and low in vivo systemic toxicity as it was able to promote a higher survival rate for the larvae in the study. In the present study, the antifungal potential of the plant extracts and the safety of use in vivo were also verified, since the extract of the C. longa plant and its isolated phytocompound curcumin did not affect the survival of the larvae, remaining similar to the control group that was inoculated only PBS being . The present study elucidated important findings regarding the application of plant products in PDT against Candida spp. since the effect of this therapy was equal to or even better than nystatin.

5. Conclusions

(i)The isolated C. longa extract and photodynamic therapy using curcumin as a photosensitizer with blue LED therapy have an antifungal effect over C. albicans and C. tropicalis;(ii)C. longa extract 100 mg/mL and curcumin 200 μg/mL do not show toxicity for the invertebrate model G. mellonella.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

Acknowledgments

This research was supported by The Coordination for the Improvement of Higher Education Personnel (CAPES) by a master scholarship and The Institutional Scientific Initiation Scholarship Program (PIBIC) for Scientific Initiation Scholarship No. 831.

References

R. Baskar, K. A. Lee, R. Yeo, and K. W. Yeoh, “Cancer and radiation therapy: current advances and future directions,” International Journal of Medical Sciences, vol. 9, no. 3, pp. 193–199, 2012.
View at: Publisher Site | Google Scholar
I. Chitapanarux, S. Wongsrita, P. Sripan et al., “An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study,” BMC Oral Health, vol. 21, no. 1, p. 353, 2021.
View at: Publisher Site | Google Scholar
D. Dambroso, T. I. E. Svidzinski, A. E. Svidzinski, M. M. O. Dalalio, and R. A. Moliterno, “Radiotherapy effect on frequency of Candida spp. and on virulence of C. albicans isolated from the oral cavity of head and neck cancer patients,” Revista de Ciências Farmacêuticas Básica e Aplicada, vol. 30, no. 2, 2009.
View at: Google Scholar
S. Ganguly and A. P. Mitchell, “Mucosal biofilms of Candida albicans,” Current Opinion in Microbiology, vol. 14, no. 4, pp. 380–385, 2011.
View at: Publisher Site | Google Scholar
F. L. Mayer, D. Wilson, and B. Hube, “Candida albicans pathogenicity mechanisms,” Virulence, vol. 4, no. 2, pp. 119–128, 2013.
View at: Publisher Site | Google Scholar
I. N. Razina, M. G. Chesnokova, and V. B. Nedoseko, “The relevance of Candida spp. in chronic periodontal disease,” Stomatologiia (Mosk), vol. 96, no. 4, p. 4, 2017.
View at: Publisher Site | Google Scholar
A. B. Treviño, A. M. Gonzalez-Amaro, V. M. Gonzalez, and A. P. Guillen, “Frequency of Candida in root canals of teeth with primary and persistent endodontic infections,” Revista Iberoamericana De Micologia, vol. 35, no. 2, pp. 78–82, 2018.
View at: Publisher Site | Google Scholar
M. Negri, M. Martins, M. Henriques, T. I. E. Svidzinski, J. Azeredo, and R. Oliveira, “Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients,” Mycopathologia, vol. 169, no. 3, pp. 175–182, 2010.
View at: Publisher Site | Google Scholar
S. C. A. Chen and T. C. Sorrell, Medical Journal of Australia, Australasian Medical Publishing Company, Sydney, Australia, vol. 187, 2007.
View at: Publisher Site
C. Zhu, B. Liao, X. Ye et al., “Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis,” International Journal of Antimicrobial Agents, vol. 58, no. 3, Article ID 106394, 2021.
View at: Publisher Site | Google Scholar
N. P. Wiederhold, “Antifungal resistance: current trends and future strategies to combat,” Infection and Drug Resistance, vol. 10, pp. 249–259, 2017.
View at: Publisher Site | Google Scholar
E. M. da Silva, E. S. B. Mansano, E. S. Miazima, F. A. V. Rodrigues, L. Hernandes, and T. I. E. Svidzinski, “Radiation used for head and neck cancer increases virulence in Candida tropicalis isolated from a cancer patient,” BMC Infectious Diseases, vol. 17, no. 1, p. 783, 2017.
View at: Publisher Site | Google Scholar
C. Li, Z. Xu, S. Liu, Y. Huang, W. Duan, and X Wei, “In vivo antifungal activities of farnesol combined with antifungal drugs against murine oral mucosal candidiasis,” Biofouling, vol. 37, no. 8, pp. 818–829, 2021.
View at: Publisher Site | Google Scholar
T. J. Dougherty, C. J. Gomer, B. W. Henderson et al., “Photodynamic therapy,” JNCI Journal of the National Cancer Institute, vol. 90, no. 12, pp. 889–905, 1998.
View at: Publisher Site | Google Scholar
A. A. Hasna, R. D. Khoury, C. C. Toia et al., “In vitro evaluation of the antimicrobial effect of N-acetylcysteine and photodynamic therapy on root canals infected with enterococcus faecalis,” Iranian Endodontic Journal, vol. 15, no. 4, pp. 236–245, 2020.
View at: Publisher Site | Google Scholar
S. F. D. S. Liberato, M. R. da Cruz Vegian, A. A. Hasna et al., “Antibiofilm action of Persea americana glycolic extract over acinetobacter baumannii and absence of toxicity in galleria mellonella,” Journal of Complementary and Integrative Medicine, 2021.
View at: Publisher Site | Google Scholar
L. A. P. Gomes, L. M. A. Figueiredo, A. L. do Rosario Palma et al., “Punica granatum L. (pomegranate) extract: in vivo study of antimicrobial activity against Porphyromonas gingivalis in Galleria mellonella model,” The Scientific World Journal, vol. 2016, Article ID 8626987, 5 pages, 2016.
View at: Publisher Site | Google Scholar
E. C. C. Ferreira, T. M. Goncalves, T. C. Pereira et al., “The biocompatibility of achyrocline satureioides plant extract over human gingival fibroblasts,” RSD, vol. 10, no. 1, Article ID e37610111902, 2021.
View at: Publisher Site | Google Scholar
K. I. Priyadarsini, “The chemistry of curcumin: from extraction to therapeutic agent,” Molecules, vol. 19, no. 12, pp. 20091–20112, 2014.
View at: Publisher Site | Google Scholar
K. T. Kazantzis, K. Koutsonikoli, B. Mavroidi et al., “Curcumin derivatives as photosensitizers in photodynamic therapy: photophysical properties and in vitro studies with prostate cancer cells,” Photochemical and Photobiological Sciences, vol. 19, no. 2, pp. 193–206, 2020.
View at: Publisher Site | Google Scholar
J. Dujic, S. Kippenberger, A. R. Bosca et al., “Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model,” International Journal of Cancer, vol. 124, no. 6, pp. 1422–1428, 2009.
View at: Publisher Site | Google Scholar
R. P. A. de Matos, M. F. Calmon, C. F. Amantino et al., “Effect of curcumin-nanoemulsion associated with photodynamic therapy in cervical carcinoma cell lines,” BioMed Research International, vol. 2018, Article ID 4057959, 11 pages, 2018.
View at: Publisher Site | Google Scholar
K. Neelofar, S. Shreaz, B. Rimple, S. Muralidhar, M. Nikhat, and L. A. Khan, “Curcumin as a promising anticandidal of clinical interest,” Canadian Journal of Microbiology, vol. 57, no. 3, pp. 204–210, 2011.
View at: Publisher Site | Google Scholar
L. N Dovigo, A. C. Pavarina, A. P. D. Ribeiro et al., “Investigation of the photodynamic effects of curcumin against Candida albicans,” Photochemistry and Photobiology, vol. 87, no. 4, pp. 895–903, 2011.
View at: Publisher Site | Google Scholar
D. D. C. R. Picco, L. L. R. Cavalcante, R. L. B. Trevisan, A. E. S. Gabriel, M. C. Borsatto, and S. A. M. Corona, “Effect of curcumin-mediated photodynamic therapy on streptococcus mutans and Candida albicans: a systematic review of in vitro studies,” Photodiagnosis and Photodynamic Therapy, vol. 27, pp. 455–461, 2019.
View at: Publisher Site | Google Scholar
L. N. Dovigo, A. C. Pavarina, J. C. Carmello, A. L. Machado, I. L. Brunetti, and V. S. Bagnato, “Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin,” Lasers in Surgery and Medicine, vol. 43, no. 9, pp. 927–934, 2011.
View at: Publisher Site | Google Scholar
A. A. Hasna, D. P. Santos, T. R. G. de Oliveira, A. B. A. Pinto, C. R. Pucci, and J. L. L. Marques, “Apicoectomy of perforated root canal using bioceramic cement and photodynamic therapy,” International Journal of Dentistry, vol. 2020, Article ID 6677588, 8 pages, 2020.
View at: Publisher Site | Google Scholar
A. Abu Hasna, C. H. Ferrari, and C. A. T. Carvalho, “Endodontic treatment of a large periapical cyst with the aid of antimicrobial photodynamic therapy-case report,” Brazilian Dental Science, vol. 22, no. 4, pp. 561–568, 2019.
View at: Publisher Site | Google Scholar
E. F. Nardini, T. S. Almeida, T. M. Yoshimura, M. S. Ribeiro, R. J. Cardoso, and A. S. Garcez, “The potential of commercially available phytotherapeutic compounds as new photosensitizers for dental antimicrobial PDT: a photochemical and photobiological in vitro study,” Photodiagnosis and Photodynamic Therapy, vol. 27, pp. 248–254, 2019.
View at: Publisher Site | Google Scholar
M. A. Freitas, A. H. Pereira, J. G. Pinto, A. Casas, and J. Ferreira-Strixino, “Bacterial viability after antimicrobial photodynamic therapy with curcumin on multiresistant Staphylococcus aureus,” Future Microbiology, vol. 14, no. 9, pp. 739–748, 2019.
View at: Publisher Site | Google Scholar
A. H. C. Pereira, L. M. C. Marcolino, J. G. Pinto, and J. F. Strixino, “Evaluation of the photodynamic therapy with curcumin on L. Braziliensis and L. major amastigotes,” Antibiotics, vol. 10, p. 634, 2021.
View at: Publisher Site | Google Scholar
H. Abdulrahman, L. Misba, S. Ahmad, and A. U. Khan, “Curcumin induced photodynamic therapy mediated suppression of quorum sensing pathway of pseudomonas aeruginosa: an approach to inhibit biofilm in vitro,” Photodiagnosis and Photodynamic Therapy, vol. 30, Article ID 101645, 2020.
View at: Publisher Site | Google Scholar
M. L. A. D. Lestari and G. Indrayanto, “Curcumin,” Profiles of Drug Substances, Excipients and Related Methodology, vol. 39, pp. 113–204, 2014.
View at: Google Scholar
M. C. Andrade, A. P. D. Ribeiro, L. N. Dovigo et al., “Effect of different pre-irradiation times on curcumin-mediated photodynamic therapy against planktonic cultures and biofilms of Candida spp,” Archives of Oral Biology, vol. 58, no. 2, pp. 200–210, 2013.
View at: Publisher Site | Google Scholar
J. Ma, H. Shi, H. Sun, J. Li, and Y. Bai, “Antifungal effect of photodynamic therapy mediated by curcumin on Candida albicans biofilms in vitro,” Photodiagnosis and Photodynamic Therapy, vol. 27, pp. 280–287, 2019.
View at: Publisher Site | Google Scholar
F. M. Samadi, S. Suhail, M. Sonam et al., “Antifungal efficacy of herbs,” Journal of Oral Biology and Craniofacial Research, vol. 9, no. 1, pp. 28–32, 2019.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Vanessa Marques Meccatti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

690

Downloads

560

Citations